Cargando…
Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis
PURPOSE OF REVIEW: At the time of diagnosis, systemic sclerosis (SSc) is often well established with significant irreversible tissue and organ damage. Definitions of ‘early SSc’ have been proposed, which include the presence of SSc-associated autoantibodies. In addition, functional autoantibodies th...
Autores principales: | Choi, May Y., Fritzler, Marvin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029444/ https://www.ncbi.nlm.nih.gov/pubmed/27387266 http://dx.doi.org/10.1097/BOR.0000000000000325 |
Ejemplares similares
-
Genetics of systemic sclerosis: recent advances
por: Ramos, Paula S., et al.
Publicado: (2015) -
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit
por: Kakkar, Vishal, et al.
Publicado: (2022) -
Contribution of keratinocytes to dermal fibrosis
por: Russo, Barbara, et al.
Publicado: (2022) -
Cellular Therapies in Systemic Sclerosis: Recent Progress
por: van Rhijn-Brouwer, Femke C. C., et al.
Publicado: (2016) -
Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero
por: Hedlund, Malin, et al.
Publicado: (2020)